المؤلفون: Lee, CJ, Kim, S, Tecca, HR, Bo-Subait, S, Phelan, R, Brazauskas, R, Buchbinder, D, Hamilton, BK, Battiwalla, M, Majhail, NS, Lazarus, HM, Shaw, PJ, Marks, DI, Litzow, MR, Chhabra, S, Inamoto, Y, DeFilipp, Z, Hildebrandt, GC, Olsson, RF, Kasow, KA, Liesveld, JL, Rotz, SJ, Badawy, SM, Bhatt, NS, Yared, JA, Page, KM, Arellano, ML, Kent, M, Farhadfar, N, Seo, S, Hematti, P, Freytes, CO, Rovo, A, Ganguly, S, Nathan, S, Burns, L, Shaw, BE, Muffly, LS

المصدر: Blood advances. 4(6):983-992

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:143304125

المؤلفون: Parsons HM; Division of Health Policy and Management, School of Public Health, University of Minnesota, Minneapolis, MN, USA., Muffly LS; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA, USA., Garcia A; Quantitative Sciences Unit, Stanford University, Stanford, CA, USA., Zhang A; Quantitative Sciences Unit, Stanford University, Stanford, CA, USA., Miller K; Quantitative Sciences Unit, Stanford University, Stanford, CA, USA., Van Riper D; Minnesota Population Center, University of Minnesota, Minneapolis, MN, USA., Knowles K; Minnesota Population Center, University of Minnesota, Minneapolis, MN, USA., Keegan TH; Department of Internal Medicine, Division of Hematology/Oncology, University of California Davis School of Medicine, Sacramento, CA, USA.

المصدر: JNCI cancer spectrum [JNCI Cancer Spectr] 2024 Jul 01; Vol. 8 (4).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE

مواضيع طبية MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Health Services Accessibility*/statistics & numerical data , Travel*/statistics & numerical data , Cancer Care Facilities*/statistics & numerical data, Humans ; Adolescent ; Male ; Female ; Young Adult ; Adult ; United States ; Time Factors ; Logistic Models ; Registries

المؤلفون: Bader CS; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Pavlova A; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Lowsky R; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Muffly LS; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Shiraz P; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Arai S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Johnston LJ; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Rezvani AR; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Weng WK; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Miklos DB; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Frank MJ; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Tamaresis JS; Biomedical Data Sciences, Stanford University, Stanford, CA., Agrawal V; Department of Hematology and Hematopoietic Stem Cell Transplantation, City of Hope, Duarte, CA., Bharadwaj S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Sidana S; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Shizuru JA; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA., Fernhoff NB; Orca Biosystems, Inc, Menlo Park, CA., Putnam A; Orca Biosystems, Inc, Menlo Park, CA., Killian S; Orca Biosystems, Inc, Menlo Park, CA., Xie BJ; 3T Biosciences, South San Francisco, CA., Negrin RS; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA., Meyer EH; Stanford Blood and Marrow Transplantation and Cellular Therapy Division, Stanford School of Medicine, Stanford University, Stanford, CA.; Cellular Immune Tolerance Program, Stanford Department of Medicine, Stanford University, Stanford, CA.

المصدر: Blood advances [Blood Adv] 2024 Mar 12; Vol. 8 (5), pp. 1105-1115.

نوع المنشور: Randomized Controlled Trial; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/pathology , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods, Humans ; Tacrolimus/therapeutic use ; Immunosuppressive Agents/therapeutic use ; Tissue Donors

المؤلفون: Muffly LS; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA., Parsons HM; Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN., Miller K; Quantitative Sciences Unit, Stanford University, Stanford, CA., Li Q; Division of Hematology/Oncology, University of California Davis, Davis, CA., Brunson A; Division of Hematology/Oncology, University of California Davis, Davis, CA., Keegan TH; Division of Hematology/Oncology, University of California Davis, Davis, CA.

المصدر: JCO oncology practice [JCO Oncol Pract] 2023 Dec; Vol. 19 (12), pp. 1190-1198. Date of Electronic Publication: 2023 Oct 27.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE

مواضيع طبية MeSH: Survival Rate* , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy, Adolescent ; Female ; Humans ; Male ; Young Adult ; Medically Uninsured ; Proportional Hazards Models ; Adult

المؤلفون: Sidana S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA. surbhi.sidana@stanford.edu., Hosoya H; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Jensen A; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA, USA., Liu L; City of Hope Cancer Center, Duarte, CA, USA., Goyal A; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Hovanky V; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Sahaf B; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA.; Cancer Correlative Science Unit, Stanford University, Stanford, CA, USA., Bharadwaj S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Latchford T; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Arai S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Leahy S; City of Hope Cancer Center, Duarte, CA, USA., Mei M; City of Hope Cancer Center, Duarte, CA, USA., Budde LE; City of Hope Cancer Center, Duarte, CA, USA., Muffly LS; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Frank MJ; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Dahiya S; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Htut M; City of Hope Cancer Center, Duarte, CA, USA., Miklos D; Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA., Janakiram M; City of Hope Cancer Center, Duarte, CA, USA.

المصدر: Blood cancer journal [Blood Cancer J] 2023 Oct 13; Vol. 13 (1), pp. 158. Date of Electronic Publication: 2023 Oct 13.

نوع المنشور: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/therapy , Receptors, Chimeric Antigen*, Humans ; Bendamustine Hydrochloride ; B-Cell Maturation Antigen ; Cyclophosphamide/therapeutic use ; Immunotherapy, Adoptive ; Cell- and Tissue-Based Therapy

المؤلفون: Spinner MA; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA.; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Sica RA; Division of Oncology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY., Tamaresis JS; Department of Biomedical Data Science, Stanford University, Stanford, CA., Lu Y; Department of Biomedical Data Science, Stanford University, Stanford, CA., Chang C; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Lowsky R; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Frank MJ; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Johnston LJ; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Miklos DB; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Muffly LS; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Negrin RS; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Rezvani AR; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Shiraz P; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Shizuru JA; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Weng WK; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA., Binkley MS; Department of Radiation Oncology, Stanford University, Stanford, CA., Hoppe RT; Department of Radiation Oncology, Stanford University, Stanford, CA., Advani RH; Division of Oncology, Department of Medicine, Stanford University, Stanford, CA., Arai S; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, CA.

المصدر: Blood [Blood] 2023 Jun 01; Vol. 141 (22), pp. 2727-2737.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Hodgkin Disease*/pathology , Hematopoietic Stem Cell Transplantation*/adverse effects, Humans ; Middle Aged ; Transplantation, Autologous ; Immune Checkpoint Inhibitors/therapeutic use ; Neoplasm Recurrence, Local/therapy ; Brentuximab Vedotin/therapeutic use

المؤلفون: Kennedy VE; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California, USA., Hui G; Department of Medicine, Stanford University, Stanford, California, USA., Azenkot T; Department of Medicine, University of California, Davis, California, USA., Gaut D; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, California, USA., Wieduwilt MJ; Section of Hematology/Oncology, Department of Medicine, University of Oklahoma, Oklahoma City, Oklahoma, USA., Oliai C; Division of Hematology/Oncology, Department of Medicine, University of California, Los Angeles, California, USA., Jonas BA; Division of Hematology/Oncology, Department of Medicine, University of California, Davis, California, USA., Mittal V; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California, USA., Logan AC; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California, USA., Muffly LS; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University, Stanford, California, USA., Mannis GN; Division of Hematology, Department of Medicine, Stanford University, Stanford, California, USA.

المصدر: American journal of hematology [Am J Hematol] 2022 Jun 01; Vol. 97 (6), pp. E191-E194. Date of Electronic Publication: 2022 Mar 18.

نوع المنشور: Letter

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Bridged Bicyclo Compounds, Heterocyclic*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Humans ; Sulfonamides/therapeutic use ; Transplantation, Homologous

المؤلفون: Kennedy VE; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California., Keegan THM; Center for Oncology Hematology Outcomes Research and Training, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, California., Li Q; Center for Oncology Hematology Outcomes Research and Training, Division of Hematology and Oncology, University of California Davis School of Medicine, Sacramento, California., Maguire FB; California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, California., Muffly LS; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University Medical Center, Stanford, California.

المصدر: Cancer [Cancer] 2022 Jan 01; Vol. 128 (1), pp. 139-149. Date of Electronic Publication: 2021 Aug 26.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cohort Studies ; Humans ; Middle Aged ; National Cancer Institute (U.S.) ; Remission Induction ; United States/epidemiology

المؤلفون: Lemieux C; Department of Medicine, Stanford University, Stanford, CA, USA.; Division of Hematology and Medical Oncology, Department of Medicine, Université Laval, Québec, QC, Canada., Muffly LS; Department of Medicine, Stanford University, Stanford, CA, USA., Iberri DJ; Department of Medicine, Stanford University, Stanford, CA, USA., Craig JK; Department of Medicine, Stanford University, Stanford, CA, USA., Johnston LJ; Department of Medicine, Stanford University, Stanford, CA, USA., Lowsky R; Department of Medicine, Stanford University, Stanford, CA, USA., Shiraz P; Department of Medicine, Stanford University, Stanford, CA, USA., Rezvani AR; Department of Medicine, Stanford University, Stanford, CA, USA., Frank MJ; Department of Medicine, Stanford University, Stanford, CA, USA., Weng WK; Department of Medicine, Stanford University, Stanford, CA, USA., Meyer E; Department of Medicine, Stanford University, Stanford, CA, USA., Shizuru JA; Department of Medicine, Stanford University, Stanford, CA, USA., Arai S; Department of Medicine, Stanford University, Stanford, CA, USA., Liedtke M; Department of Medicine, Stanford University, Stanford, CA, USA., Negrin RS; Department of Medicine, Stanford University, Stanford, CA, USA., Miklos DB; Department of Medicine, Stanford University, Stanford, CA, USA., Sidana S; Department of Medicine, Stanford University, Stanford, CA, USA. Surbhi.sidana@stanford.edu.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2021 Nov; Vol. 56 (11), pp. 2664-2671. Date of Electronic Publication: 2021 Jun 23.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Multiple Myeloma*/therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Disease-Free Survival ; Humans ; Neoplasm Recurrence, Local ; Retrospective Studies ; Salvage Therapy ; Transplantation, Autologous

المؤلفون: Bhatt NS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington. Electronic address: nbhatt@fredhutch.org., Brazauskas R; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin; Division of Biostatistics, Institute of Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin., Salit RB; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Syrjala K; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Bo-Subait S; Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota., Tecca H; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Badawy SM; Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Baker KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida., Bejanyan N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Byrne M; Vanderbilt University Medical Center, Nashville, Tennessee., Dias A; Beth Israel Deaconess Medical Center, Boston, Massachusetts., Farhadfar N; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, Florida., Freytes CO; Texas Transplant Institute, San Antonio, Texas., Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas., Hashmi S; Department of Internal Medicine, Mayo Clinic, Minnesota; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates., Hayashi RJ; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Washington University School of Medicine in St Louis, St Louis, Missouri., Hong S; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Inamoto Y; Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Jamani K; Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada., Kasow KA; University of North Carolina, Chapel Hill, North Carolina., Khera N; Department of Hematology/Oncology, Mayo Clinic, Phoenix, Arizona., Krem MM; Markey Cancer Center, University of Kentucky College of Medicine, Lexington, Kentucky., Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio., Lee CJ; Utah Blood and Marrow Transplant Program at Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Lee S; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Majhail NS; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Malone AK; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Marks DI; Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, United Kingdom., Mau LW; Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota., Mayo SJ; Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Ontario, Canada., Muffly LS; Division of Blood and Marrow Transplantation, Stanford University, Stanford, California., Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago, Illinois., Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Page KM; Division of Pediatric Blood and Marrow Transplantation, Duke University Medical Center, Durham, North Carolina., Preussler J; Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, Minnesota., Rangarajan HG; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Children's hospital, Columbus, Ohio., Rotz SJ; Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic Children's Hospital, Cleveland, Ohio., Salooja N; Imperial College London, London, United Kingdom., Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Schears R; University of Central Florida, Department of Emergency Medicine, Orlando, Florida., Schechter-Finkelstein T; Hospital for Sick Children, Toronto, Ontario Canada., Schiller G; Hematological Malignancy/Stem Cell Transplant Program, David Geffen School of Medicine at UCLA, Los Angeles, California., Shah AJ; Division of Stem Cell Transplantation and Regenerative Medicine, Lucille Packard Children's Hospital, Stanford School of Medicine, Palo Alto, California., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Wang T; Division of Transplantation and Cellular Therapy, University of Miami, Miami, Florida., Wirk B; Penn State Cancer Institute, Bone Marrow Transplant Program, Hershey, Pennsylvania., Battiwalla M; Sarah Cannon Blood Cancer Network, Nashville, Tennessee., Schoemans H; Department of Hematology, University Hospitals Leuven and KU Leuven, Leuven, Belgium., Hamilton B; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Buchbinder D; Division of Pediatric Hematology, Children's Hospital of Orange County, Orange, California., Phelan R; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Shaw B; Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2021 Aug; Vol. 27 (8), pp. 679.e1-679.e8. Date of Electronic Publication: 2021 Apr 22.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation* , Return to Work*, Female ; Humans ; Neoplasm Recurrence, Local ; Survivors ; Transplantation, Homologous ; United States ; Young Adult